Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1992 Oct;90(4):1467-78.
doi: 10.1172/JCI116014.

Characterization of the cDNA of a broadly reactive neutralizing human anti-gp120 monoclonal antibody

Affiliations

Characterization of the cDNA of a broadly reactive neutralizing human anti-gp120 monoclonal antibody

W A Marasco et al. J Clin Invest. 1992 Oct.

Abstract

The F105 mAb, identified in an HIV-1-infected individual, binds to a discontinuous epitope on the HIV-1 gp120 envelope glycoprotein, blocks the binding of gp120 to the CD4 viral receptor, and neutralizes a broad range of HIV-1 isolates. This study reports the primary nucleotide and deduced amino acid sequences of the rearranged heavy and light chains of the mAb F105. This IgG1k mAb uses a VH gene member of the VH4 gene family (V71-4) and is productively rearranged with a D-D fusion product of the dlr4 and da4 germline DH genes and the JH5 gene. This rearranged heavy chain gene expresses the VH4-HV2a idiotope, which is seen in human monoclonal IgM cold agglutinins. The F105 Vk appears to be derived from the Humvk325 germline gene and is rearranged with a Jk2 gene. For both chains, the mutational pattern in the rearranged VH and VL genes is indicative of an antigen-driven process. These studies show that production of a broadly neutralizing anti-HIV-1 antibody that recognizes determinants within the CD4 recognition site of the envelope glycoprotein is achieved by rearrangement of the V71-4 and Humvk325 germline variable region genes along with selected individual point mutations in the rearranged genes.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Science. 1986 Jul 11;233(4760):215-9 - PubMed
    1. Clin Immunol Immunopathol. 1987 Jun;43(3):403-11 - PubMed
    1. J Mol Biol. 1987 Jun 20;195(4):761-8 - PubMed
    1. J Exp Med. 1988 Mar 1;167(3):840-52 - PubMed
    1. J Clin Invest. 1988 Aug;82(2):469-75 - PubMed

Publication types

MeSH terms